Literature DB >> 3941004

Synthetic Salmonella-type lipid A antigen with high serological specificity.

N Kasai, S Arata, J Mashimo, K Okuda, Y Aihara, S Kotani, H Takada, T Shiba, S Kusumoto, M Imoto.   

Abstract

A synthetic compound (compound 516), beta(1-6)-linked D-glucosamine disaccharide 1,4'-bisphosphate, which is acylated by (R)-3-hexadecanoyloxytetradecanoyl, (R)-3-hydroxytetradecanoyl, (R)-3-dodecanoyloxytetradecanoyl, and (R)-3-tetradecanoyloxytetradecanoyl groups at positions 2,3,2', and 3', respectively, exhibited in vitro antigenic reactivity of high specificity comparable to that of free lipid A from Salmonella minnesota R595. This was confirmed by an enzyme-linked immunosorbent assay and an enzyme-linked immunosorbent assay inhibition test with monoclonal and conventional antibodies. The results of comparative analysis performed with several synthetic lipid A analogs as well as three monosaccharide derivatives suggested that the complete structure involving both phosphate groups at the C-1 and C-4' positions and the 3-acyloxyacyl groups at the C-2, C-2', and C-3' positions of the glucosamine disaccharide are required for the expression of the serological specificity of Salmonella-type lipid A. This was deduced from the observations that compound 506, a synthetic Escherichia coli-type lipid A which has the same structure as that of compound 516, except that 3-hydroxytetradecanoyl group is substituted for an acyloxyacyl residue at the C-2 position, exhibited significantly reduced antigenic reactivity as compared with compound 516 and that the replacement by the hydrogen atom of the phosphoryl group at the C-1 position or by 3-hydroxytetradecanoyl or tetradecanoyl groups of acyl residues at the 2, 3, 2', and 3' positions of compound 516 results in a marked reduction of reactivity with monoclonal antibodies 5G and 36G. Similar results were obtained by assays with conventional rabbit antibodies, but the structural difference between compounds 516 and 506 could not be distinguished by these polyclonal antibodies. The results of cross-reactions among synthetic analogs with monoclonal antibodies 161M and 1-9M, which have been confirmed to exhibit different serological specificities from the 5G or 36G antibody, also suggested that the nature and linkage of fatty acyl residues as well as the backbone structure of lipid A play an important role in determining serological specificity of the lipid A molecule.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3941004      PMCID: PMC261063          DOI: 10.1128/iai.51.1.43-48.1986

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  13 in total

1.  Biological properties of lipid A from Shigella sonnei.

Authors:  C Lugowski; E Romanowska
Journal:  Eur J Biochem       Date:  1974-10-01

2.  Enzyme-linked immunosorbent assay, Elisa. 3. Quantitation of specific antibodies by enzyme-labeled anti-immunoglobulin in antigen-coated tubes.

Authors:  E Engvall; P Perlmann
Journal:  J Immunol       Date:  1972-07       Impact factor: 5.422

3.  A new method for the extraction of R lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1969-06

4.  Preparation and properties of antisera against the lipid-A component of bacterial lipopolysaccharides.

Authors:  C Galanos; O Lüderitz; O Westphal
Journal:  Eur J Biochem       Date:  1971-12-22

5.  Biological activities of analogues of lipid A based chemically on the revised structural model. Comparison of mediator-inducing, immunomodulating and endotoxic activities.

Authors:  S Kanegasaki; Y Kojima; M Matsuura; J Y Homma; A Yamamoto; Y Kumazawa; K Tanamoto; T Yasuda; T Tsumita; M Imoto
Journal:  Eur J Biochem       Date:  1984-09-03

6.  Endotoxic glycolipid as a potent depressor of the hepatic drug-metabolizing enzyme systems in mice.

Authors:  K Egawa; N Kasai
Journal:  Microbiol Immunol       Date:  1979       Impact factor: 1.955

7.  Lipid A fractions analyzed by a technique involving thin-layer chromatography and enzyme-linked immunosorbent assay.

Authors:  I Mattsby-Baltzer; C R Alving
Journal:  Eur J Biochem       Date:  1984-01-16

8.  Lipopolysaccharides: structural principles and biologic activities.

Authors:  O Lüderitz; K Tanamoto; C Galanos; G R McKenzie; H Brade; U Zähringer; E T Rietschel; S Kusumoto; T Shiba
Journal:  Rev Infect Dis       Date:  1984 Jul-Aug

9.  T cell allotypic determinants encoded by genes linked to the immunoglobulin heavy chain locus. I. Establishment of monoclonal antibodies against allotypic determinants.

Authors:  Y Aihara; I Tadokoro; K Katoh; M Minami; K Okuda
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

10.  Biological activities of lipopolysaccharides and lipid A from Rhodospirillaceae.

Authors:  C Galanos; J Roppel; J Weckesser; E T Rietschel; H Mayer
Journal:  Infect Immun       Date:  1977-05       Impact factor: 3.441

View more
  8 in total

1.  Characterization of the epitope specificity of murine monoclonal antibodies directed against lipid A.

Authors:  H M Kuhn; L Brade; B J Appelmelk; S Kusumoto; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1992-06       Impact factor: 3.441

2.  Legionella pneumophila growth restriction in permissive macrophages cocultured with nonpermissive lipopolysaccharide-activated macrophages.

Authors:  S Arata; C Newton; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1993-12       Impact factor: 3.441

3.  Low endotoxic activities of synthetic Salmonella-type lipid A with an additional acyloxyacyl group on the 2-amino group of beta (1-6) glucosamine disaccharide 1,4'-bisphosphate.

Authors:  S Kotani; H Takada; I Takahashi; M Tsujimoto; T Ogawa; T Ikeda; K Harada; H Okamura; T Tamura; S Tanaka
Journal:  Infect Immun       Date:  1986-06       Impact factor: 3.441

4.  Legionella pneumophila growth restriction and cytokine production by murine macrophages activated by a novel Pseudomonas lipid A.

Authors:  S Arata; N Kasai; T W Klein; H Friedman
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  An artificial glycoconjugate containing the bisphosphorylated glucosamine disaccharide backbone of lipid A binds lipid A monoclonal antibodies.

Authors:  L Brade; O Holst; H Brade
Journal:  Infect Immun       Date:  1993-10       Impact factor: 3.441

6.  The immunogenicity and antigenicity of lipid A are influenced by its physicochemical state and environment.

Authors:  L Brade; K Brandenburg; H M Kuhn; S Kusumoto; I Macher; E T Rietschel; H Brade
Journal:  Infect Immun       Date:  1987-11       Impact factor: 3.441

Review 7.  Immunopharmacology of lipid A mimetics.

Authors:  William S Bowen; Siva K Gandhapudi; Joseph P Kolb; Thomas C Mitchell
Journal:  Adv Pharmacol       Date:  2013

8.  Tumor necrosis factor-inducing activities of lipid A preparations from Pseudomonas diminuta and Pseudomonas vesicularis.

Authors:  S Arata; K Nakaya; H Furuhashi; Y Nakamura; T Hirayama; J Mashimo; N Kasai
Journal:  Jpn J Cancer Res       Date:  1988-05
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.